http://www.usantidoping.org/ Current Press Releases for USADA May 9, 2013

USADA announced today that, Tyler Flanagan, of Mammoth Lakes, Calif., an athlete in the sport of snowboarding, has accepted a two-year suspension for an anti-doping rule violation based on his refusal to submit to a sample collection.

On March 14, 2013, Flanagan, 20, refused to provide a sample as requested by a doping control officer during an out-of-competition test. Under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Ski Federation (FIS) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code, an athlete’s refusal to provide a sample when notified that he has been selected for doping control constitutes a rule violation.

Flanagan accepted a two- year period of ineligibility, which began on May 8, 2013 the day he accepted the sanction. As a result of the sanction, Flanagan is also disqualified from all competitive results obtained on and subsequent to March 14, 2013, the date upon which he refused to submit to sample collection, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org ]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release Flanagan May 2013.pdf5/9/2013 April 19, 2013

USADA announced today that Yosmani Pol Rodriguez of Weston, Fla., an athlete in the sport of cycling, has tested positive for a prohibited substance and accepted a two-year sanction for his doping offense.

Pol Rodriguez, 32, tested positive for Dexamethasone as the result of an in-competition urine sample collected on March 10, 2012 at the Delray Beach Twilight Criterium. Dexamethasone is classified as a glucocorticosteroid on the World Anti-Doping Prohibited List and is prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (“UCI”) anti-doping rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List.

Pol Rodriguez accepted a two-year period of ineligibility, which began on September 2, 2012, the date of his last competition. Pol Rodriguez has also been disqualified from all competitive results achieved on and subsequent to March 10, 2012, including the forfeiture of any medals, points and prizes.
 
In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release - Pol-Rodriguez- April 2013.pdf4/19/2013 April 18, 2013

USADA announced today that Shawn Crawford of Culver City, Calif., an athlete in the sport of track & field, has received a two-year suspension for committing an anti-doping rule violation in which he failed to file his whereabouts information.

Crawford, 35, was a member of the USADA National Testing Pool from 2001 through the beginning of 2013, which consists of a select group of athletes subject to certain whereabouts requirements in order to be located for USADA Out-of-Competition testing. Crawford failed to comply with the whereabouts requirements and, as a result, accrued three Whereabouts Failures within an 18-month period. Under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Association of Athletics Federations (IAAF) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”), the combination of three Whereabouts Failures within an 18-month period constitutes a rule violation. A Whereabouts Failure for National Testing Pool athletes includes failure to provide required quarterly whereabouts filings and/or failure to be available for testing due to inaccurate or incomplete information provided by the athlete.

Crawford’s two-year period of ineligibility, began on April 17, 2013, the date he received the sanction. As a result of the violation, Crawford has been disqualified from all competitive results achieved on and subsequent to November 17, 2012 the date of his third Whereabouts Failure, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]> http://www.usada.org/files/active/resources/pre ss_releases/PressRelease-Crawford-4.18.2013.pdf4/18/2013 March 22, 2013

USADA announced today that Erik Morales of San Ysidro, California, an athlete in the sport of professional boxing, has tested positive for a prohibited substance and has received a two-year sanction as a result of his violation.

Morales, 36, tested positive for Clenbuterol, in two separate urine samples collected out-of-competition on October 3, 2012 and October 10, 2012 in Mexico. Clenbuterol is a prohibited Anabolic Agent under the USADA Protocol for Olympic and Paralympic Movement Testing, which has adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List. Both samples were collected as part of an anti-doping testing program conducted by USADA for a professional boxing match that took place on October 20, 2012, in Brooklyn, New York. 

Professional boxing does not have a universally-implemented, WADA-accredited anti-doping program, and as a result of the lack of effective testing, many professional boxers and event organizers have contracted with USADA to conduct comprehensive anti-doping programs prior to and during their fights.

The anti-doping programs implemented by USADA in professional boxing include proper athlete education, numerous no-notice out-of-competition sample collections for both blood and urine, and lab analysis, including special analysis such as CIR and hGH, all to be completed prior to the fight.

USADA conducts testing programs for professional boxing matches only when both athletes contractually agree to participate in the anti-doping program, which stipulates agreeing to abide by the applicable anti-doping rules, including the rules regarding the adjudication process and sanctioning.  Morales’ contractual agreement for this anti-doping testing program included his acknowledgement that USADA would be the results management authority to adjudicate any adverse analytical findings in accordance with the rules. In addition, the appropriate boxing commission was notified prior to the fight, and within 48 hours of USADA receiving the information, that there was a potential anti-doping rule violation.

Morales has been offered the opportunity to participate in the full, fair legal process under the rules, but has indicated to USADA that he would not like to move forward with the independent arbitration process, and as a result, has received a two-year period of ineligibility and the disqualification of all competitive results obtained subsequent to October 3, 2012, including the forfeiture of any medals, points and prizes.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
Media Relations
Phone: (719) 785-2046
E-mail:  media@usada.org

 

]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release Morales March 2013.pdf3/22/2013 March 12, 2013

USADA announced today that Mike Hersey of Centerville, Mass., an athlete in the sport of Paralympic-class sailing, has tested positive for a prohibited substance found in his medication and has accepted a public warning for his rule violation.

Hersey, 49, tested positive for Hydrochlorothiazide and Chlorothiazide as the result of an out-of-competition urine sample collected on November 16, 2012. Hydrochlorothiazide and Chlorothiazide are classified as diuretics on the World Anti-Doping Prohibited List and, therefore, prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Sailing Federation (ISAF) anti-doping rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List.

Hydrochlorothiazide and Chlorothiazide are classified as Specified Substances, and therefore the presence of Hydrochlorothiazide and Chlorothiazide in an athlete’s sample can result in a reduced sanction. Hersey was taking a prescribed medication in a therapeutic dose under the care of a physician; however, Hersey failed to obtain a therapeutic use exemption in advance of the test as required by the rules.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.


CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org ]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release - Hersey- March 2013.pdf3/12/2013 March 8, 2013

USADA announced today that Roger Wenzel, of Yukon, Okla., an athlete in the sport of Track & Field, has tested positive for prohibited substances and received a two-year sanction for committing anti-doping rule violations.

Wenzel, 64, tested positive for Modafanil, a prohibited stimulant, and for exogenous Anabolic Androgenic Steroids in a urine sample collected on August 4, 2012 at the USA Masters Outdoor Track & Field Championships in Lisle, Ill. Modafanil and exogenous Anabolic Androgenic Steroids are prohibited substances under the USADA Protocol for Olympic Movement Testing and the International Association of Athletics Federations (IAAF) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (Code) and the World Anti-Doping Agency Prohibited List.

Competitors at the USA Masters Outdoor Track & Field Championships are advised in advance of the competition that they are subject to drug testing and of the requirement to comply with sport drug testing rules. Mr. Wenzel advised USADA that he was taking the substances under a doctor’s care, but despite being aware of the rules regarding the requirement to apply for a therapeutic use exemption (TUE) prior to competition, he did not seek to obtain a TUE to use either Modafinil or Anabolic Androgenic Steroids in advance of the competition.

Wenzel’s two-year period of ineligibility began on September 7, 2012, the date he accepted a provisional suspension. Wenzel has also been disqualified from all competitive results achieved on and subsequent to August 4, 2012, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release-Wenzel - March 2013.pdf3/8/2013 February 22, 2013

USADA announced today that Graham Aldredge, of Flagstaff, Ariz., an athlete in the sport of cycling, has acknowledged committing an anti-doping rule violation and has accepted his sanction.

Aldredge, 22, failed to appear to provide a sample at the BMC Racing Cup (Gränichen), on June 17, 2012, in, Gränichen Switzerland. Failure to appear is a violation of the applicable rules under the USADA Protocol for Olympic Movement Testing and the International Cycling Union (UCI) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.

Aldredge accepted a sanction resulting in a 16-month period of ineligibility, beginning on June 17, 2012, the date he failed to appear and provide a sample. Aldredge informed USADA that after withdrawing from the race due to illness, he failed to do his due diligence in determining whether he had been selected to provide a sample for anti-doping testing. As a result of the sanction, Aldredge is also disqualified from all results obtained during any competition in which he competed in beginning on June 17, 2012, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release - Graham Aldredge 2013.pdf2/22/2013 February 20, 2013

“We have provided Mr. Armstrong several opportunities to assist in our ongoing efforts to clean up the sport of cycling.  Following his recent television interview, we again invited him to come in and provide honest information, and he was informed in writing by the World Anti-Doping Agency (WADA) that this was the appropriate avenue for him if he wanted to be part of the solution.  Over the last few weeks he has led us to believe that he wanted to come in and assist USADA, but was worried of potential criminal and civil liability if he did so. Today we learned from the media that Mr. Armstrong is choosing not to come in and be truthful and that he will not take the opportunity to work toward righting his wrongs in sport.
 
At this time we are moving forward with our investigation without him and we will continue to work closely with WADA and other appropriate and responsible international authorities to fulfill our promise to clean athletes to protect their right to compete on a drug free playing field.”

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.


CONTACT:
USADA Media Releations
Phone: (719) 785-2000
media@usada.org
]]> http://www.usada.org/files/active/resources/pre ss_releases/Feb20.2013statement.pdf2/20/2013 February 6, 2013

“We have been in communication with Mr. Armstrong and his representatives and we understand that he does want to be part of the solution and assist in the effort to clean up the sport of cycling. We have agreed to his request for an additional two weeks to work on details to hopefully allow for this to happen.”

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]> http://www.usada.org/files/active/resources/pre ss_releases/Press ReleaseFebruary62013.pdf2/6/2013 January 17, 2013

“Tonight, Lance Armstrong finally acknowledged that his cycling career was built on a powerful combination of doping and deceit.

His admission that he doped throughout his career is a small step in the right direction. But if he is sincere in his desire to correct his past mistakes, he will testify under oath about the full extent of his doping activities.”

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org


]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release -Statement on Lance Armstrong Interview.pdf1/17/2013 January 15, 2013

Following discussions with the UCI Independent Commission regarding its Terms of Reference, USADA and many others contacted by the Commission have all explained how important it is for the future of clean sport for the Commission to adopt additional terms of reference including a limited Truth and Reconciliation and Amnesty Program for the sport of cycling and to implement provisions that will protect Commission witnesses from retaliation by the UCI.  USADA understands the Commission agrees with these proposals, but that the UCI has rejected these important components for the Commission and refuses to allow the Commission's Terms of Reference to be modified.

USADA CEO Travis T. Tygart said, "UCI's refusal to agree to allow a limited opportunity for riders to come forward and be truthful without fear of retribution or retaliation from the UCI obviously calls into question the UCI's commitment to a full and thorough investigation and creates grave concern that the UCI has blindfolded and handcuffed this Independent Commission to ensure a pre-determined outcome.  The current terms of reference are not good for clean athletes or moving this sport forward to a better future.”


About USADA

USADA is the non-profit, independent and non-governmental entity responsible for the testing and results management process in the U.S. for athletes in the Olympic and Paralympic Movement, upholding the Olympic ideal of fair play, and representing the interests of athletes. USADA is dedicated to preserving the integrity of sport through research initiatives and educational programs. The agency manages a drug reference phone hotline and Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as curricula, themed brochures and nutrition and dietary guides, easy-reference wallet cards for the prohibited substance list, periodic newsletters, and protocol and policy reference publications, all of which can be found at www.USADA.org. 

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org ]]> http://www.usada.org/files/active/resources/pre ss_releases/StatementUCI CommissionJanuary2013.pdf1/15/2013 January 10, 2013

We congratulate the players and owners in Major League Baseball for including in-season blood testing for human growth hormone and longitudinal testing for testosterone. This is a strong statement by the players and the league not only confirming the scientific validity of the HGH blood test and the benefit of longitudinal testing, but also the importance of clean athletes’ rights and the integrity of the game.  This agreement, following the recent Congressional hearings on testing in the NFL, leaves no reason for the NFLPA not to step up and implement the same to give its players an equal level of protection and confidence that they deserve a level, drug-free playing field in the NFL.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release -MLB testing program.pdf1/10/2013 December 31, 2012

USADA announced today that Cyril Jay-Rayon of Los Angeles, Calif., an athlete in the sport of cycling, has tested positive for a prohibited substance and has accepted a sanction for his anti-doping rule violation.

Jay-Rayon, 46, provided a urine sample on September 30, 2012, during an in-competition test, at the 24 Hour Nationals in Colorado Springs, Colo., that resulted in an adverse analytical finding for the stimulant Modafinil. Modafinil is prohibited in-competition under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) anti-doping rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List.

Jay-Rayon’s 18-month period of ineligibility began on October 23, 2012, the date he accepted a provisional suspension. As a result of his anti-doping rule violation, Jay-Rayon has been disqualified from all competitive results obtained on and subsequent to September 30, 2012, the date his sample was collected, including forfeiture of any medals, points and prizes.

“Although I used Provigil for work and not to enhance my athletic performance, I should have been more aware about the substances I put in my body before competition,” said Jay-Rayon. “I would like to apologize to my fellow competitors and the race organizers for my carelessness.”

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.


CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release -Jay- Rayon - December 2012.pdf12/31/2012
December 21, 2012

USADA announced today that Maggie Vessey of Beverly Hills, California, an athlete in the sport of track & field, has tested positive for a prohibited substance found in her medication and has accepted a public warning and loss of results for her rule violation.

Vessey, 30, tested positive for Canrenone as the result of an in-competition urine sample collected on September 4, 2012 at the IAAF World Challenge Zagreb in Zagreb, Croatia. Canrenone is prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Association of Athletics Federations (IAAF)anti-doping rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List.

Canrenone is classified as a Specified Substance, and therefore the presence of Canrenone in an athlete’s sample can result in a reduced sanction. Vessey was taking a prescribed medication, in a therapeutic dose under the care of a physician. The medication when metabolized resulted in the adverse analytical finding.

In addition to the public warning, Vessey has been disqualified from all competitive results obtained at the IAAF World Challenge Zagreb including forfeiture of any medals, points and prizes.

"I took a prescription skincare product that was prescribed to me by my family practitioner, that I did not know contained a diuretic.  As soon as I was notified of my positive test, I cooperated with USADA and provided them everything they asked for in order to demonstrate that I made an honest mistake, and that the medication did not enhance my performance in any way,” said Vessey. “I have since applied for a Therapeutic Use Exemption for this medication.  I share in USADA's belief in clean sport, and look forward to the upcoming track season."

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
Media Relations Manager
Phone: (719) 785-2000
E-mail:  media@usada.org

]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release - Vessey - December 2012.pdf12/21/2012
December 21, 2012

USADA announced today that Joseph Hall, of Boxsprings, Georgia, an athlete in the sport of Shooting, has tested positive for a prohibited substance and accepted a suspension for his doping offense.

Hall, 26, tested positive for the metabolites 19-norandrosterone and 19-noretiocholanolone in a sample collected on June 11, 2012, at the 2012 USA Shooting National Championships in Columbus, Georgia, indicating the presence of an anabolic agent prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Shooting Sport Federation(“ISSF”) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code and the WADA Prohibited List.

For his offense, USADA announced that Hall will serve a one-year period of ineligibility, which began on July 9, 2012, the day he accepted a provisional suspension.  Hall has been disqualified from all competitive results achieved on and subsequent to May 30, 2012, the date the 2012 USA Shooting National Championships started, including forfeiture of any medals, points, and prizes.


In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release -Hall December 2012 .pdf12/21/2012 December 14, 2012

USADA announced today that Christian Hesch, an athlete in the sport of Track & Field, has accepted a two-year suspension for committing an anti-doping rule violation.

Hesch voluntarily admitted having used erythropoietin (EPO) which is prohibited under the USADA Protocol for Olympic Movement Testing and the International Association of Athletics Federations (IAAF) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (Code) and the World Anti-Doping Agency Prohibited List.

Hesch’s two-year period of ineligibility began on September 26, 2012, the date he admitted his use of EPO to USADA. Under the Code Mr. Hesch was eligible for a six-month reduction of the period of ineligibility based on his voluntary admission to USADA regarding his doping activities. As a result, he will be required to serve the remaining 18-months of his sanction. Hesch has also been disqualified from all competitive results achieved on and subsequent to August 27, 2010, the date he admitted to first using EPO, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release-Hesch - December 2012.pdf12/14/2012 November 9, 2012

USADA announced today that Mark Fretta, of Colorado Springs, Colo., an athlete in the sport of Triathlon, has committed an anti-doping rule violation and received a sanction for his doping offense.

Fretta, 35, received a four-year period of ineligibility after variations in his individual longitudinal blood profile as well as other documentary evidence indicated the use of Erythropoiesis-Stimulating Agents such as Erythropoietin (“EPO”).  Erythropoiesis-Stimulating Agents are prohibited in the class of Peptide Hormones which are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Triathlon Union Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency (“WADA”) Prohibited List.

USADA conducts longitudinal blood data collection and comprehensive scientific review to identify changes in biological parameters that may be indicative of doping. The program consists of collecting athlete samples to measure an athlete’s unique biological parameters, including, but not limited to, hemoglobin concentration, hematocrit, and percentage reticulocytes, over time to establish an individual longitudinal blood profile. Variations and fluctuations in these measurements when compared to an athlete’s own established longitudinal blood profile can be indicative of prohibited, performance-enhancing drug use, and can result in an anti-doping rule violation under the Code.

Fretta’s four-year period of ineligibility began on June 11, 2012, the date he accepted a provisional suspension.  As a result of the violation, Fretta has been disqualified from all competitive results achieved on and subsequent to August 18, 2010, the date USADA collected the first blood sample that was included in Fretta’s individual longitudinal blood profile.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]> http://www.usada.org/files/active/resources/pre ss_releases/PressRelease-Fretta.pdf11/9/2012 October 22, 2012

“Today, the UCI made the right decision in the Lance Armstrong case.  Despite its prior opposition to USADA's investigation into doping on the U.S. Postal Service cycling team and within the sport, USADA is glad that the UCI finally reversed course in this case and has made the credible decision available to it.

This determination to uphold USADA’s decision on the U.S. Postal Services case does not by itself clean up cycling nor does it ensure the sport has moved past the obstacles that allowed doping to flourish in the age of EPO and blood transfusions.  For cycling to truly move forward and for the world to know what went on in cycling, it is essential that an independent and meaningful Truth and Reconciliation Commission be established so that the sport can fully unshackle itself from the past.  There are many more details of doping that are hidden, many more doping doctors, and corrupt team directors and the omerta has not yet been fully broken.

Sanctioning Lance Armstrong and the riders who came forward truthfully should not be seen as penance for an era of pervasive doping.  There must be more action to combat the system that took over the sport.  It is important to remember that while today is a historic day for clean sport, it does not mean clean sport is guaranteed for tomorrow. Only an independent Truth and Reconciliation Commission can fully start cycling on the path toward true reform and provide hope for a complete break from the past.”

About USADA
USADA is the non-profit, independent and non-governmental entity responsible for the testing and results management process in the U.S. for athletes in the Olympic and Paralympic Movement, upholding the Olympic ideal of fair play, and representing the interests of athletes. USADA is dedicated to preserving the integrity of sport through research initiatives and educational programs. The agency manages a drug reference phone hotline and Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as curricula, themed brochures and nutrition and dietary guides, easy-reference wallet cards for the prohibited substance list, periodic newsletters, and protocol and policy reference publications, all of which can be found at www.USADA.org. 

]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release - Travis Tygart Statement on UCI decision -October 2012.pdf10/22/2012
October 10, 2012 

Today, we are sending the ‘Reasoned Decision’ in the Lance Armstrong case and supporting information to the Union Cycliste International (UCI), the World Anti-Doping Agency (WADA), and the World Triathlon Corporation (WTC). The evidence shows beyond any doubt that the US Postal Service Pro Cycling Team ran the most sophisticated, professionalized and successful doping program that sport has ever seen.  

The evidence of the US Postal Service Pro Cycling Team-run scheme is overwhelming and is in excess of 1000 pages, and includes sworn testimony from 26 people, including 15 riders with knowledge of the US Postal Service Team (USPS Team) and its participants’ doping activities. The evidence also includes direct documentary evidence including financial payments, emails, scientific data and laboratory test results that further prove the use, possession and distribution of performance enhancing drugs by Lance Armstrong and confirm the disappointing truth about the deceptive activities of the USPS Team, a team that received tens of millions of American taxpayer dollars in funding. 

Together these different categories of eyewitness, documentary, first-hand, scientific, direct and circumstantial evidence reveal conclusive and undeniable proof that brings to the light of day for the first time this systemic, sustained and highly professionalized team-run doping conspiracy. All of the material will be made available later this afternoon on the USADA website at www.usada.org.

The USPS Team doping conspiracy was professionally designed to groom and pressure athletes to use dangerous drugs, to evade detection, to ensure its secrecy and ultimately gain an unfair competitive advantage through superior doping practices. A program organized by individuals who thought they were above the rules and who still play a major and active role in sport today. 

The evidence demonstrates that the ‘Code of Silence’ of performance enhancing drug use in the sport of cycling has been shattered, but there is more to do.  From day one, we always hoped this investigation would bring to a close this troubling chapter in cycling’s history and we hope the sport will use this tragedy to prevent it from ever happening again.

Of course, no one wants to be chained to the past forever, and I would call on the UCI to act on its own recent suggestion for a meaningful Truth and Reconciliation program.  While we appreciate the arguments that weigh in favor of and against such a program, we believe that allowing individuals like the riders mentioned today to come forward and acknowledge the truth about their past doping may be the only way to truly dismantle the remaining system that allowed this “EPO and Blood Doping Era” to flourish. Hopefully, the sport can unshackle itself from the past, and once and for all continue to move forward to a better future.

Our mission is to protect clean athletes by preserving the integrity of competition not only for today’s athletes but also the athletes of tomorrow.  We have heard from many athletes who have faced an unfair dilemma — dope, or don’t compete at the highest levels of the sport. Many of them abandoned their dreams and left sport because they refused to endanger their health and participate in doping. That is a tragic choice no athlete should have to make.

It took tremendous courage for the riders on the USPS Team and others to come forward and speak truthfully. It is not easy to admit your mistakes and accept your punishment. But that is what these riders have done for the good of the sport, and for the young riders who hope to one day reach their dreams without using dangerous drugs or methods.

These eleven (11) teammates of Lance Armstrong, in alphabetical order, are Frankie Andreu, Michael Barry, Tom Danielson, Tyler Hamilton, George Hincapie, Floyd Landis, Levi Leipheimer, Stephen Swart, Christian Vande Velde, Jonathan Vaughters and David Zabriskie.

The riders who participated in the USPS Team doping conspiracy and truthfully assisted have been courageous in making the choice to stop perpetuating the sporting fraud, and they have suffered greatly. In addition to the public revelations, the active riders have been suspended and disqualified appropriately in line with the rules. In some part, it would have been easier for them if it all would just go away; however, they love the sport, and they want to help young athletes have hope that they are not put in the position they were -- to face the reality that in order to climb to the heights of their sport they had to sink to the depths of dangerous cheating.

I have personally talked with and heard these athletes’ stories and firmly believe that, collectively, these athletes, if forgiven and embraced, have a chance to leave a legacy far greater for the good of the sport than anything they ever did on a bike.

Lance Armstrong was given the same opportunity to come forward and be part of the solution. He rejected it.

Instead he exercised his legal right not to contest the evidence and knowingly accepted the imposition of a ban from recognized competition for life and disqualification of his competitive results from 1998 forward. The entire factual and legal basis on the outcome in his case and the other six active riders’ cases will be provided in the materials made available online later today. Two other members of the USPS Team, Dr. Michele Ferrari and Dr. Garcia del Moral, also received lifetime bans for perpetrating this doping conspiracy.

Three other members of the USPS Team have chosen to contest the charges and take their cases to arbitration: Johan Bruyneel, the team director; Dr. Pedro Celaya, a team doctor; and Jose “Pepe” Marti, the team trainer.  These three individuals will receive a full hearing before independent judges, where they will have the opportunity to present and confront the evidence, cross-examine witnesses and testify under oath in a public proceeding.

From day one in this case, as in every potential case, the USADA Board of Directors and professional staff did the job we are mandated to do for clean athletes and the integrity of sport.  We focused solely on finding the truth without being influenced by celebrity or non-celebrity, threats, personal attacks or political pressure because that is what clean athletes deserve and demand.”


CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release - Armstrong Reasoned Decision 10.10.12.pdf10/10/2012 Edwin C. Moses is named Chair, Dr. Richard Cohen, Dr. Jean Fourcroy, and Annette Salmeen are recognized for their legacy, and Dr. Cheri Blauwet, Robert Raskopf and Dr. Ken Wright become newest members

September 26, 2012

The U.S. Anti-Doping Agency (USADA) announced today that Olympic great Edwin Moses has been named Chair of the organization’s Board of Directors. Moses succeeds founding board member and previous Chair, Dr. Richard Cohen who due to term limits began his last 4 year term in 2008 and is now rotating off the board after serving the organization for 12 years, including one year as Chair. Dr. Cohen is an orthopedic surgeon and was the Chair of the Atlanta Committee for the Olympic Games Doping Control Commission. Moses has been an active supporter of anti-doping efforts for more than 20 years and was selected to fill the Chair position at the September 13th board meeting.

“The use of dangerous performance-enhancing drugs is one of the most important issues facing sport today, and our mission at USADA, to ensure that all clean athletes can compete on a level playing field, is vitally important not only for this generation of athletes but all the generations to come, “said Edwin Moses. “I have been honored to serve on the USADA Board since 2010 and as Chair I look forward to continuing to support USADA’s staff in successfully fulfilling our mission through our commitment to the highest standards of excellence.”

Joining Dr. Cohen in retirement from the USADA Board of Directors, in compliance with term limit requirements are founding board member Dr. Jean Fourcroy who has served since 2000 and Annette Salmeen, who has served on the board since 2005. Salmeen, a gold medal winning swimmer who has a doctorate in biochemistry has provided valuable input as an Olympic athlete. Salmeen served as board Secretary and has been a strong supporter of education and USADA’s commitment to inspiring True Sport.  Dr. Fourcroy, a retired medical officer with the Food and Drug Administration is a noted clinician and researcher in the field of anabolic steroids, androgens and their alternatives and has been an advocate of USADA’s scientific research endeavors.

As part of this scheduled transition, USADA is also pleased to welcome new board members Dr. Cheri Blauwet, Robert Raskopf and Dr. Ken Wright. These new board members bring a variety of valuable expertise to the USADA board, including background in higher education, sports medicine and athletic training, sports law, and involvement with Paralympic Sport including the Paralympic Games. 

 “Dr. Cohen, Dr. Fourcroy and Annette Salmeen will be greatly missed and their contributions to this organization are immeasurable,” said USADA CEO Travis T. Tygart. “They have all been fearless in their commitment to USADA’s mission and their leadership and devotion to clean athletes and the integrity of sport has been a large part of USADA’s growth and success over the last 12 years. We are excited to welcome new board members Dr. Cheri Blauwet, Robert Raskopf and Dr. Ken Wright and look forward to continued success under the leadership of Edwin Moses.”

With Edwin Moses taking on the role of Chair after having previously served as Vice Chair, Dr. Richard Clark will assume the role of Vice Chair and with the retirement of Annette Salmeen, Marcia Lee Taylor will serve as Secretary.

Current USADA Board of Directors
Edwin C. Moses – Sc.D honoris causia,  Chair
Richard Clark, MD, PhD- Vice Chair
Marcia Lee Taylor- Secretary
Carl Swenson - Treasurer
John Bardis
Cheri Blauwet, MD
Don L. Gambril
Jim Kooler, DrPH
Robert Raskopf
Ken Wright,DA

Edwin C. Moses, Sc.D honoris causia, Chair
Track & Field great, Edwin Moses, won Olympic gold medals in 1976 and 1984, three World Cup titles, two World Championships and broke the World Record four times as a 400 meter hurdler. As a qualified physicist with a MBA degree, he pioneered the development of policies against the use of performance-enhancing drugs while Chairman of the United States Olympic Committee’s (USOC) substance abuse, research and education committee (CSARE). Moses served on the International Olympic Committee as a member of the Athletes Commission, Medical Commission and Ethics Commission as well as on the Athletes Advisory and Executive Committees of the USOC.

Moses also serves as the Chairman of The Laureus World Sports Academy, an association of sporting legends, which uses the positive influence of sport as a tool for social change around the globe. Edwin attended Morehouse College, where he earned a B.S in Physics, and went on to receive his MBA from Pepperdine University, and the degree of Doctor of Science, honoris causa, from University of Massachusetts, Boston.

New USADA Board of Director Members

Cheri Blauwet, MD
Cheri Blauwet, MD is a former Paralympic athlete in the sport of wheelchair racing, competing for the United States Team in three Paralypmic Games (Sydney '00, Athens '04, Beijing '08) and bringing home a total of seven Paralympic medals. She is also a two-time winner of both the Boston and New York City Marathons, and a four-time winner of the Los Angeles Marathon. Cheri has been nominated for an ESPY Award, the Laureus World Sports Award, and Women's Sports Foundation Athlete of the Year. She remains a member of the International Paralympic Committee (IPC) Medical Committee, and has published on the power of sport to promote both well-being and disability rights for individuals with mobility impairment. In 2004, she was a winner of the American Association of People with Disabilities Paul Hearne Award, given annually to three emerging leaders nation-wide for their potential to change the face of the disability movement.  Cheri is a graduate of Stanford Medical School, and is currently a senior resident in Physical Medicine and Rehabilitation at Spaulding Rehabilitation Hospital, a teaching affiliate of Harvard Medical School.

Robert Raskopf
Mr. Raskopf is a prominent trial and appellate lawyer in the intellectual property, media, sports, entertainment and privacy bars.  His practice includes the following substantive areas:  trademark, copyright, libel/First Amendment, privacy/publicity, patent, product configuration, trade dress, trade secrets and advertising. He has litigated many cases through trial and appeal, both jury and non-jury, in state and federal court, and has been counsel of record in over 60 reported decisions.  Mr. Raskopf also has a long history in privacy-related matters.  He also counsels multinational clients concerning compliance with the growing web of global privacy and data protection laws.  Mr. Raskopf is recognized as a leading lawyer nationally in Chambers USA in sports law and in New York in media & entertainment: copyright & contract disputes.  Sports Business International also listed him as one of the "World's 20 Most Influential Lawyers" in 2010.

Ken Wright, DA
Dr. Ken Wright is a Professor and Director of the Sport Management Program at The University of Alabama.  Dr. Wright received the Sayers "Bud" Miller Distinguished Educator of the Year Award (2000), Distinguished Athletic Trainer Award (2006), and Athletic Trainer Service Award (1996) from the National Athletic Trainers' Association (NATA) along with Outstanding Alumnus from the College of Health Sciences at Eastern Kentucky University (2001), and Academic Excellence Award from The University of Alabama College of Education (1996-97).

Dr. Wright has numerous publications to his credit including a series of seven videos titled, Sports Medicine Evaluation Series, a series of six videos titled Sports Medicine Taping, a computer assisted instructional program titled Sports Injuries and two textbooks, Basic Athletic Training, 5th edition and Preventive Techniques: Taping/Wrapping Techniques and Protective Devices, 3rd edition.  Since 1990, Dr. Wright has presented at 16 different NATA Annual Meeting & Clinical Symposium and been invited to present to sport medicine professional in the countries of China, Japan, Canada and the United Kingdom. Additionally, Ken has served on the editorial board of the Journal of Athletic Training, Physical Therapy in Sport, and Sports Medicine Update.
Having served as Head Athletic Trainer at the University of North Carolina at Charlotte (1981-1988) and Morehead State University (1978-1981), Dr. Wright has been highly active in the National Athletic Trainers’ Association (i.e. Educational Multimedia Committee, Journal of Athletic Training, JRC-AT Site Visitor, Education Council, and conference coordinator for SEATA and Mid-Atlanta athletic trainer meetings) and the United States Olympic Committee. Also, he has collaborated with United States Anti-Doping Agency (Doping Control Officer and Chair of DCO Advisory Committee) and has been selected to work at the 2012 Olympic Games in London, United Kingdom, 2010 Olympic Games in Vancouver, Canada, and 2002 Olympic Games in Salt Lake City, Utah.
Dr. Wright received his Doctor of Arts from Middle Tennessee State University (1984), Masters of Science from Syracuse University (1976), and a Bachelor of Science degree from Eastern Kentucky University (1974).

About USADA
USADA is the non-profit, independent and non-governmental entity responsible for the testing and results management process in the U.S. for athletes in the Olympic and Paralympic Movement, upholding the Olympic ideal of fair play, and representing the interests of athletes. USADA is dedicated to preserving the integrity of sport through research initiatives and educational programs. The agency manages a drug reference phone hotline and Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as curricula, themed brochures and nutrition and dietary guides, easy-reference wallet cards for the prohibited substance list, periodic newsletters, and protocol and policy reference publications, all of which can be found at www.USADA.org. 

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail: media@usada.org


]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release - USADA BOD - September 2012.pdf9/26/2012 September 14 , 2012

USADA announced today that Julio Cruz, of Hialeah Gardens, Fla., an athlete in the sport of cycling, has tested positive for a prohibited substance and accepted a suspension for his doping offense.

Cruz, 43, tested positive for Methylhexaneamine, a stimulant, as a result of a urine sample collected at the Parkland Circuit -BBPA, on April 15, 2012, in Parkland, Fla. Stimulants are prohibited under the USADA Protocol for Olympic Movement Testing and the International Cycling Union (UCI) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Methylhexaneamine is classified as a Specified Substance, and therefore the presence of that substance in an athlete’s sample can result in a reduced sanction.  

Cruz accepted a sanction resulting in a 6-month period of ineligibility, beginning on August 27, 2012, the date he accepted a provisional suspension. As a result of the sanction, Cruz is also disqualified from all competitive results obtained on and subsequent to April 15, 2012, the date of the Parkland Circuit - BBPA, including forfeiture of any medals, points, and prizes.

Cruz informed USADA that at the time of his positive test he had taken a supplement which upon further review listed 1,3-Dimethylpentylamine (Apple Geranium) on the label. 1,3-Dimethylpentylamine is a name sometimes used by supplement companies to refer to methylhexaneamine. USADA issued an athlete advisory on June 16, 2011 to make athletes aware of the concerns regarding methylhexaneamine, including issues involving supplement labeling. That advisory can be found on the USADA website at http://www.usada.org/media/methylhexaneamine-and-dietary-supplements. USADA also provides cautionary dietary supplement information to athletes, their support personnel and the public at www.supplement411.org.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org


]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release - Cruz September 2012.pdf9/14/2012 September 11, 2012 – USADA announced today that Debbie Dunn, of Norfolk, Va., an athlete in the sport of track & field, has tested positive for a prohibited substance and accepted a two-year suspension for her doping offense.

Laboratory analysis of a sample provided by Dunn at the U.S. Olympic Team Trials, on June 24, 2012, in Eugene, Ore., resulted in an Adverse Analytical Finding for an anabolic agent. Anabolic Androgenic Steroids are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Association of Athletics Federations (IAAF) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code and the WADA Prohibited List.

Dunn, 34, accepted a two-year period of ineligibility, which began on August 1, 2012, the date she accepted a provisional suspension. As a result of the sanction, Dunn has been disqualified from all competitive results achieved on and subsequent to June 22, 2012, the date the U.S. Olympic Team Trials began, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─
CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release - Dunn - September 2012.pdf9/11/2012 September 7, 2012

USADA announced today that Gabriele Guarini, an Italian athlete in the sport of cycling, has accepted a two-year suspension for committing an anti-doping rule violation.

Guarini, 49, admitted taking a banned Oxygen-Enhancing Peptide Hormone after testing positive as the result of a sample collected at the Gran Fondo New York on May 20, 2012. Oxygen-Enhancing Peptide Hormones are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”), and the World Anti-Doping Agency Prohibited List.

In his communications with USADA, Guarini accepted responsibility for his actions and apologized to those involved with the Gran Fondo New York including its organizers and competitors.

Guarini’s two-year period of ineligibility, began on June 3, 2012.  As a result of the violation, Guarini has been disqualified from all competitive results achieved on and subsequent to May 20, 2012, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release-Guarini-September 2012.pdf9/7/2012 August 31, 2012

USADA announced today that Steven Andrus of East Lansing, Mich., an athlete in the sport of wrestling, has tested positive for a prohibited substance and accepted a suspension for his doping offense.

Andrus, 22, tested positive for tetrahydrocannabinol acid, a marijuana metabolite in the class of Cannabinoids, and an Amphetamine in the class of non-specified stimulants as the result of a sample collected on April 21, 2012 at the U.S. Olympic Trials in Iowa City, Iowa. Andrus established that the Amphetamine came from an ADHD medication; however Andrus had not gained advanced approval to use the medication during competition as required under the rules. Both substances are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Federation of Associated Wrestling Styles (FILA) Anti- Doping Rules, both of which have adopted the World Anti-Doping Code and the WADA Prohibited List. 

Andrus accepted a one- year period of ineligibility, which began on May 25, 2012, the day he accepted a provisional sanction.

As a result of the doping violation, Andrus has been disqualified from his competitive results achieved on and subsequent to April 21, 2012, the day he provided his sample, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy- reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release - Andrus August 2012.pdf8/31/2012 August 31, 2012

USADA announced today that Cesar Lopez of El Paso, Texas, an athlete in the sport of Cycling, has tested positive for a prohibited substance and accepted a suspension for his doping offense.

Lopez, 18, tested positive for carboxy-THC, a marijuana metabolite in the class of Cannabinoids, in a sample collected on July 13, 2012 at the Junior Track Nationals in Trexlertown, Pa. Cannabinoids are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code and the WADA Prohibited List. Cannabinoids are listed as Specified Substances, and therefore the presence of those substances in an athlete’s sample can result in a reduced sanction.

Lopez accepted a three-month period of ineligibility, which began on August 2, 2012, the day he accepted a provisional sanction. The period of ineligibility was suspended and reduced to time served, after his successful completion of a USADA anti-doping educational program.

As a result of the doping violation, Lopez has been disqualified from his competitive results achieved on July 13, 2012, the day his sample was collected, through and including August 30, 2012, the date he completed the doping education program, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
USADA Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]> http://www.usada.org/files/active/resources/pre ss_releases/Press Release - Lopez September 2012.pdf8/31/2012